What does CUSIP 868459108 represent in this 13F holders report?

CUSIP 868459108 is the security identifier for SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in Q4 2017?

294 institutional investors reported SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock for Q4 2017. Use the holders table for investor-level position and value details.

SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN)

CUSIP: 868459108

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class: Equity / Common Stock
Shares outstanding: 57,572,193
Total 13F shares: 49,688,862
Share change: -1,223,415
Total reported value: $1,981,355,785
Put/Call ratio: 188%
Price per share: $39.85
Number of holders: 294
Value change: -$48,904,009
Number of buys: 133
Number of sells: 133

Quarterly Holders Quick Answers

What is CUSIP 868459108?
CUSIP 868459108 identifies SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2018
Previous quarter: Q3 2017

Recent filing periods for CUSIP 868459108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	12%	6,781,836	$271,272,000	—	30 Sep 2017	13F
VANGUARD GROUP INC	13F	Company	7.8%	4,489,064	$179,563,000	—	30 Sep 2017	13F
Invesco Ltd.	13F	Company	3.6%	2,062,652	$82,507,000	—	30 Sep 2017	13F
Bank of New York Mellon Corp	13F	Company	2.6%	1,483,043	$59,321,000	—	30 Sep 2017	13F
STATE STREET CORP	13F	Company	2.4%	1,410,379	$56,416,000	—	30 Sep 2017	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	2.2%	1,267,424	$50,696,000	—	30 Sep 2017	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	2.2%	1,255,688	$50,226,000	—	30 Sep 2017	13F
Champlain Investment Partners, LLC	13F	Company	2.1%	1,229,975	$49,199,000	—	30 Sep 2017	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	2.1%	1,224,317	$48,973,000	—	30 Sep 2017	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	2%	1,127,218	$45,089,000	—	30 Sep 2017	13F
Fiera Capital Corp	13F	Company	1.8%	1,044,672	$41,787,000	—	30 Sep 2017	13F
Ranger Investment Management, L.P.	13F	Company	1.7%	988,840	$39,554,000	—	30 Sep 2017	13F
Russell Investments Group, Ltd.	13F	Company	1.5%	836,340	$33,453,000	—	30 Sep 2017	13F
ASHFORD CAPITAL MANAGEMENT INC	13F	Company	1.3%	754,304	$30,172,000	—	30 Sep 2017	13F
NEUMEIER POMA INVESTMENT COUNSEL LLC	13F	Company	1.3%	721,420	$28,857,000	—	30 Sep 2017	13F
GLENMEDE TRUST CO NA	13F	Company	1.3%	721,097	$28,842,000	—	30 Sep 2017	13F
AMERIPRISE FINANCIAL INC	13F	Company	1.2%	681,792	$27,271,000	—	30 Sep 2017	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.2%	672,681	$26,907,000	—	30 Sep 2017	13F
LOOMIS SAYLES & CO L P	13F	Company	1.1%	648,406	$25,936,000	—	30 Sep 2017	13F
NORTHERN TRUST CORP	13F	Company	1.1%	647,900	$25,916,000	—	30 Sep 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	1.1%	615,584	$24,624,000	—	30 Sep 2017	13F
EMERALD ADVISERS, LLC	13F	Company	1.1%	605,920	$24,237,000	—	30 Sep 2017	13F
SCOUT INVESTMENTS, INC.	13F	Company	0.98%	565,900	$22,636,000	—	30 Sep 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.93%	534,509	$21,380,000	—	30 Sep 2017	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.87%	502,870	$20,115,000	—	30 Sep 2017	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.86%	493,069	$19,722,000	—	30 Sep 2017	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.85%	491,283	$19,651,000	—	30 Sep 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.78%	449,251	$17,970,000	—	30 Sep 2017	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.71%	406,775	$16,271,000	—	30 Sep 2017	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.7%	404,970	$16,199,000	—	30 Sep 2017	13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F	Company	0.7%	402,565	$16,103,000	—	30 Sep 2017	13F
NORGES BANK	13F	Company	0.7%	401,193	$16,048,000	—	30 Sep 2017	13F
OppenheimerFunds, Inc.	13F	Company	0.69%	396,474	$15,859,000	—	30 Sep 2017	13F
Granite Investment Partners, LLC	13F	Company	0.64%	371,154	$14,846,000	—	30 Sep 2017	13F
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income	13F	Company	0.62%	354,955	$14,200,000	—	30 Sep 2017	13F
FALCON POINT CAPITAL, LLC	13F	Company	0.58%	335,659	$13,963,000	—	30 Sep 2017	13F
Polar Capital LLP	13F	Company	0.59%	338,956	$13,558,000	—	30 Sep 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.59%	338,692	$13,546,000	—	30 Sep 2017	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.58%	335,847	$13,434,000	—	30 Sep 2017	13F
Hodges Capital Management Inc.	13F	Company	0.57%	328,945	$13,158,000	—	30 Sep 2017	13F
CASTLEARK MANAGEMENT LLC	13F	Company	0.55%	316,940	$12,678,000	—	30 Sep 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.52%	301,323	$12,054,000	—	30 Sep 2017	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.46%	266,655	$10,666,000	—	30 Sep 2017	13F
KORNITZER CAPITAL MANAGEMENT INC /KS	13F	Company	0.46%	266,265	$10,651,000	—	30 Sep 2017	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.46%	266,146	$10,646,000	—	30 Sep 2017	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.45%	258,676	$10,347,000	—	30 Sep 2017	13F
NORTHPOINTE CAPITAL LLC	13F	Company	0.44%	251,526	$10,061,000	—	30 Sep 2017	13F
SEI INVESTMENTS CO	13F	Company	0.43%	248,193	$9,928,000	—	30 Sep 2017	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.43%	246,571	$9,862,840	—	30 Sep 2017	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.42%	243,000	$9,720,000	—	30 Sep 2017	13F

Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) as of Q4 2017

As of 31 Dec 2017, SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) was held by 294 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,688,862 shares. The largest 10 holders included BlackRock Inc., Vanguard Group Inc, Invesco Ltd., STATE STREET CORP, Bank of New York Mellon Corp, DIMENSIONAL FUND ADVISORS LP, RICE HALL JAMES & ASSOCIATES, LLC, ACADIAN ASSET MANAGEMENT LLC, Champlain Investment Partners, LLC, and ROTHSCHILD ASSET MANAGEMENT INC. This page lists 294 institutional shareholders reporting positions in this security for the Q4 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2017 vs Q3 2017 Across Filers

Q3 2017 holders

273

Q4 2017 holders

294

Holder diff

Investor	Q3 2017 Shares	Q4 2017 Shares	Share Diff	Share Chg %	Q3 2017 Value $	Q4 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.